Subcutaneous (SC) insulin delivery lowers blood glucose levels; however, inevitable episodes of hyper- and hypoglycaemia still occur due to slow or insufficient SC insulin uptake, overdosing, and systemic hyperinsulinemia, which may also alter plasma lipid profiles [[2], [3], [4], [5]]. The gene discussed is INS; the disease is hyperinsulinism.